This is higher than other GLP-1s, which had discontinuation rates of 6.1% (tirzepatide), 8.0% (semaglutide) and 10.3% (orforglipron)
For the first time, the top pharmaceutical companies have now agreed to balance pricing, increase Medicare and Medicaid access and support U.S
Download our guide to Managing GLP-1 Costs and Supporting Optimal Health Outcomes for ideas on how to start building your own strategy now
However, these gastrointestinal side effects were observed during dosage escalation
Documentation of Harm: Evidence of the financial and personal impact of the injury, including medical bills, pay stubs, and personal journals detailing the daily effects of the condition
Start Your Transformation Today GLP-1 medications like Mounjaro and Ozempic have changed the game in weight loss